References
- Watt, F. M. and B. L. Hogan. 2000. Out of Eden: stem cells and their niches. Science 287: 1427-1430. https://doi.org/10.1126/science.287.5457.1427
- Thomson, J. A., J. Itskovitz-Eldor, S. S. Shapiro, M. A. Waknitz, J. J. Swiergiel, V. S. Marshall, and J. M. Jones. 1998. Embryonic stem cell lines derived from human blastocysts. Science 282: 1145-1147. https://doi.org/10.1126/science.282.5391.1145
- Friedenstein, A. J., R. K. Chailakhjan, and K. S. Lalykina. 1970. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 3: 393-403.
- Nussbaum, J., E. Minami, M. A. Laflamme, J. A. Virag, C. B. Ware, A. Masino, V. Muskheli, L. Pabon, H. Reinecke, and C. E. Murry. 2007. Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response. FASEB. J. 21: 1345-1357. https://doi.org/10.1096/fj.06-6769com
- Kon, E., A. Muraglia, A. Corsi, P. Bianco, M. Marcacci, I. Martin, A. Boyde, I. Ruspantini, P. Chistolini, M. Rocca, R. Giardino, R. Cancedda, and R. Quarto. 2000. Autologous bone marrow stromal cells loaded onto porous hydroxyapatite ceramic accelerate bone repair in critical-size defects of sheep long bones. J. Biomed. Mater. Res. 49: 328-337. https://doi.org/10.1002/(SICI)1097-4636(20000305)49:3<328::AID-JBM5>3.0.CO;2-Q
- Solchaga, L. A., J. S. Temenoff, J. Gao, A. G. Mikos, A. I. Caplan, and V. M. Goldberg. 2005. Repair of osteochondral defects with hyaluronan- and polyester-based scaffolds. Osteoarthritis Cartilage 13: 297-309. https://doi.org/10.1016/j.joca.2004.12.016
- Horwitz, E. M., K. Le Blanc, M. Dominici, I. Mueller, I. Slaper-Cortenbach, F. C. Marini, R. J. Deans, D. S. Krause, A. Keating ; International Society for Cellular Therapy. 2005. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 7: 393-395. https://doi.org/10.1080/14653240500319234
- Dominici, M., K. Le Blanc, I. Mueller, I. Slaper-Cortenbach, F. Marini, D. Krause, R. Deans, A. Keating, D. Prockop, and E. Horwitz. 2006. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8: 315-317. https://doi.org/10.1080/14653240600855905
- Amado, L. C., A. P. Saliaris, K. H. Schuleri, M. St John, J. S. Xie, S. Cattaneo, D. J. Durand, T. Fitton, J. Q. Kuang, G. Stewart, S. Lehrke, W. W. Baumgartner, B. J. Martin, A. W. Heldman, and J. M. Hare. 2005. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc. Natl. Acad. Sci. USA 102: 11474-11479. https://doi.org/10.1073/pnas.0504388102
- Lin, Y. T., Y. Chern, C. K. Shen, H. L. Wen, Y. C. Chang, H. Li, T. H. Cheng, and H. M. Hsieh-Li. 2011. Human mesenchymal stem cells prolong survival and ameliorate motor deficit through trophic support in Huntington's disease mouse models. PLoS One 6: e22924. https://doi.org/10.1371/journal.pone.0022924
- Miyahara, Y., N. Nagaya, M. Kataoka, B. Yanagawa, K. Tanaka, H. Hao, K. Ishino, H. Ishida, T. Shimizu, K. Kangawa, S. Sano, T. Okano, S. Kitamura, and H. Mori. 2006. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat. Med. 12: 459-465. https://doi.org/10.1038/nm1391
- Ball, L. M., M. E. Bernardo, H. Roelofs, A. Lankester, A. Cometa, R. M. Egeler, F. Locatelli, and W. E. Fibbe. 2007. Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood 110: 2764-2767. https://doi.org/10.1182/blood-2007-04-087056
- Le Blanc, K., F. Frassoni, L. Ball, F. Locatelli, H. Roelofs, I. Lewis, E. Lanino, B. Sundberg, M. E. Bernardo, M. Remberger, G. Dini, R. M. Egeler, A. Bacigalupo, W. Fibbe, O. Ringden ; Developmental Committee of the European Group for Blood and Marrow Transplantation. 2008. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 371: 1579-1586. https://doi.org/10.1016/S0140-6736(08)60690-X
- Duijvestein, M., A. C. Vos, H. Roelofs, M. E. Wildenberg, B. B. Wendrich, H. W. Verspaget, E. M. Kooy-Winkelaar, F. Koning, J. J. Zwaginga, H. H. Fidder, A. P. Verhaar, W. E. Fibbe, G. R. van den Brink, and D. W. Hommes. 2010. Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study. Gut 59: 1662-1669. https://doi.org/10.1136/gut.2010.215152
- Ciccocioppo, R., M. E. Bernardo, A. Sgarella, R. Maccario, M. A. Avanzini, C. Ubezio, A. Minelli, C. Alvisi, A. Vanoli, F. Calliada, P. Dionigi, C. Perotti, F. Locatelli, and G. R. Corazza. 2011. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease. Gut 60: 788-798. https://doi.org/10.1136/gut.2010.214841
- Le Blanc, K., I. Rasmusson, B. Sundberg, C. Gotherstrom, M. Hassan, M. Uzunel, and O. Ringden. 2004. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363: 1439-1441. https://doi.org/10.1016/S0140-6736(04)16104-7
- Gu, Z., K. Akiyama, X. Ma, H. Zhang, X. Feng, G. Yao, Y. Hou, L. Lu, G. S. Gilkeson, R. M. Silver, X. Zeng, S. Shi, and L. Sun. 2010. Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL/lpr mice. Lupus 19: 1502-1514. https://doi.org/10.1177/0961203310373782
- Ji, S., Q. Guo, Y. Han, G. Tan, Y. Luo, and F. Zeng. 2012. Mesenchymal stem cell transplantation inhibits abnormal activation of Akt/GSK3beta signaling pathway in T cells from systemic lupus erythematosus mice. Cell Physiol. Biochem. 29: 705-712. https://doi.org/10.1159/000178590
- Zhou, K., H. Zhang, O. Jin, X. Feng, G. Yao, Y. Hou, and L. Sun. 2008. Transplantation of human bone marrow mesenchymal stem cell ameliorates the autoimmune pathogenesis in MRL/lpr mice. Cell Mol. Immunoly. 5: 417-424. https://doi.org/10.1038/cmi.2008.52
- Youd, M., C. Blickarz, L. Woodworth, T. Touzjian, A. Edling, J. Tedstone, M. Ruzek, R. Tubo, J. Kaplan, and T. Lodie. 2010. Allogeneic mesenchymal stem cells do not protect NZBxNZW F1 mice from developing lupus disease. Clin. Exp. Immunol. 161: 176-186.
- Schena, F., C. Gambini, A. Gregorio, M. Mosconi, D. Reverberi, M. Gattorno, S. Casazza, A. Uccelli, L. Moretta, A. Martini, and E. Traggiai. 2010. Interferon-gamma-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus. Arthritis Rheum. 62: 2776-2786. https://doi.org/10.1002/art.27560
- Choi, E. W., I. S. Shin, S. Y. Park, J. H. Park, J. S. Kim, E. J. Yoon, S. K. Kang, J. C. Ra, and S. H. Hong. 2012. Reversal of serologic, immunologic, and histologic dysfunction in mice with systemic lupus erythematosus by long-term serial adipose tissue-derived mesenchymal stem cell transplantation. Arthritis Rheum. 64: 243-253. https://doi.org/10.1002/art.33313
- Firestein, G. S. 2003. Evolving concepts of rheumatoid arthritis. Nature 423: 356-361. https://doi.org/10.1038/nature01661
- Liu, Y., R. Mu, S. Wang, L. Long, X. Liu, R. Li, J. Sun, J. Guo, X. Zhang, J. Guo, P. Yu, C. Li, X. Liu, Z. Huang, D. Wang, H. Li, Z. Gu, B. Liu, and Z. Li. 2010. Therapeutic potential of human umbilical cord mesenchymal stem cells in the treatment of rheumatoid arthritis. Arthritis Res. Ther. 12: R210. https://doi.org/10.1186/ar3187
- Zhou, B., J. Yuan, Y. Zhou, M. Ghawji, Jr., Y. P. Deng, A. J. Lee, A. J. Lee, U. Nair, A. H. Kang, D. D. Brand, and T. J. Yoo. 2011. Administering human adipose-derived mesenchymal stem cells to prevent and treat experimental arthritis. Clin. Immunol. 141: 328-337. https://doi.org/10.1016/j.clim.2011.08.014
- Augello, A., R. Tasso, S. M. Negrini, R. Cancedda, and G. Pennesi. 2007. Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen- induced arthritis. Arthritis Rheum. 56: 1175-1186. https://doi.org/10.1002/art.22511
- Papadopoulou, A., M. Yiangou, E. Athanasiou, N. Zogas, P. Kaloyannidis, I. Batsis, A. Fassas, A. Anagnostopoulos, and E. Yannaki. 2012. Mesenchymal stem cells are conditionally therapeutic in preclinical models of rheumatoid arthritis. Ann. Rheum. Dis. 71: 1733-1740. https://doi.org/10.1136/annrheumdis-2011-200985
- Gonzalez, M. A., E. Gonzalez-Rey, L. Rico, D. Buscher, and M. Delgado. 2009. Adipose-derived mesenchymal stem cells alleviate experimental colitis by inhibiting inflammatory and autoimmune responses. Gastroenterology 136: 978-989. https://doi.org/10.1053/j.gastro.2008.11.041
- Bouma, G. and W. Strober. 2003. The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 3: 521-533. https://doi.org/10.1038/nri1132
- Akiyama, K., C. Chen, D. Wang, X. Xu, C. Qu, T. Yamaza, T. Cai, W. Chen, L. Sun, and S. Shi. 2012. Mesenchymalstem- cell-induced immunoregulation involves FAS-ligand-/ FAS-mediated T cell apoptosis. Cell Stem Cell 10: 544-555. https://doi.org/10.1016/j.stem.2012.03.007
- Zappia, E., S. Casazza, E. Pedemonte, F. Benvenuto, I. Bonanni, E. Gerdoni, D. Giunti, A. Ceravolo, F. Cazzanti, F. Frassoni, G. Mancardi, and A. Uccelli. 2005. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106: 1755-1761. https://doi.org/10.1182/blood-2005-04-1496
- Gerdoni, E., B. Gallo, S. Casazza, S. Musio, I. Bonanni, E. Pedemonte, R. Mantegazza, F. Frassoni, G. Mancardi, R. Pedotti, and A. Uccelli. 2007. Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann. Neurol. 61: 219-227. https://doi.org/10.1002/ana.21076
-
Nauta, A. J., A. B. Kruisselbrink, E. Lurvink, R. Willemze, and W. E. Fibbe. 2006. Mesenchymal stem cells inhibit generation and function of both
$CD34^{+}$ -derived and monocyte- derived dendritic cells. J. Immunol. 177: 2080-2087. https://doi.org/10.4049/jimmunol.177.4.2080 - Jiang, X. X., Y. Zhang, B. Liu, S. X. Zhang, Y. Wu, X. D. Yu, and N. Mao. 2005. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 105: 4120-4126. https://doi.org/10.1182/blood-2004-02-0586
- Aggarwal, S. and M. F. Pittenger. 2005. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105: 1815-1822. https://doi.org/10.1182/blood-2004-04-1559
- Beyth, S., Z. Borovsky, D. Mevorach, M. Liebergall, Z. Gazit, H. Aslan, E. Galun, and J. Rachmilewitz. 2005. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105: 2214-2219. https://doi.org/10.1182/blood-2004-07-2921
-
Maccario, R., M. Podesta, A. Moretta, A. Cometa, P. Comoli, D. Montagna, L. Daudt, A. Ibatici, G. Piaggio, S. Pozzi, F. Frassoni, and F. Locatelli. 2005. Interaction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of
$CD4^{+}$ T-cell subsets expressing a regulatory/suppressive phenotype. Haematologica 90: 516-525. - Zhang, W., W. Ge, C. Li, S. You, L. Liao, Q. Han, W. Deng, and R. C. Zhao. 2004. Effects of mesenchymal stem cells on differentiation, maturation, and function of human monocyte- derived dendritic cells. Stem Cells Dev. 13: 263-271. https://doi.org/10.1089/154732804323099190
- Chiesa, S., S. Morbelli, S. Morando, M. Massollo, C. Marini, A. Bertoni, F. Frassoni, S. T. Bartolome, G. Sambuceti, E. Traggiai, and A. Uccelli. 2011. Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells. Proc. Natl. Acad. Sci. USA 108: 17384-17389. https://doi.org/10.1073/pnas.1103650108
- Spaggiari, G. M., H. Abdelrazik, F. Becchetti, and L. Moretta. 2009. MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. Blood 113: 6576-6583. https://doi.org/10.1182/blood-2009-02-203943
- Wehner, R., D. Wehrum, M. Bornhauser, S. Zhao, K. Schakel, M. P. Bachmann, U. Platzbecker, G. Ehninger, E. P. Rieber, and M. Schmitz. 2009. Mesenchymal stem cells efficiently inhibit the proinflammatory properties of 6-sulfo LacNAc dendritic cells. Haematologica 94: 1151-1156. https://doi.org/10.3324/haematol.2008.001735
- Bartholomew, A., C. Sturgeon, M. Siatskas, K. Ferrer, K. McIntosh, S. Patil, W. Hardy, S. Devine, D. Ucker, R. Deans, A. Moseley, and R. Hoffman. 2002. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol. 30: 42-48. https://doi.org/10.1016/S0301-472X(01)00769-X
- Krampera, M., S. Glennie, J. Dyson, D. Scott, R. Laylor, E. Simpson, and F. Dazzi. 2003. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen- specific T cells to their cognate peptide. Blood 101: 3722-3729. https://doi.org/10.1182/blood-2002-07-2104
- Maitra, B., E. Szekely, K. Gjini, M. J. Laughlin, J. Dennis, S. E. Haynesworth, and O. N. Koc. 2004. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant. 33: 597-604. https://doi.org/10.1038/sj.bmt.1704400
- Gonzalez-Rey, E., M. A. Gonzalez, N. Varela, F. O'Valle, P. Hernandez-Cortes, L. Rico, D. Buscher, and M. Delgado. 2010. Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis. Ann. Rheum. Dis. 69: 241-248. https://doi.org/10.1136/ard.2008.101881
- Locatelli, F., R. Maccario, and F. Frassoni. 2007. Mesenchymal stromal cells, from indifferent spectators to principal actors. Are we going to witness a revolution in the scenario of allograft and immune-mediated disorders? Haematologica 92: 872-877. https://doi.org/10.3324/haematol.11479
- Krampera, M., L. Cosmi, R. Angeli, A. Pasini, F. Liotta, A. Andreini, V. Santarlasci, B. Mazzinghi, G. Pizzolo, F. Vinante, P. Romagnani, E. Maggi, S. Romagnani, and F. Annunziato. 2006. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells 24: 386-398. https://doi.org/10.1634/stemcells.2005-0008
- Mougiakakos, D., R. Jitschin, C. C. Johansson, R. Okita, R. Kiessling, and K. Le Blanc. 2011. The impact of inflammatory licensing on heme oxygenase-1-mediated induction of regulatory T cells by human mesenchymal stem cells. Blood 117: 4826-4835. https://doi.org/10.1182/blood-2010-12-324038
- Ren, G., X. Zhao, L. Zhang, J. Zhang, A. L'Huillier, W. Ling, A. I. Roberts, A. D. Le, S. Shi, C. Shao, and Y. Shi. 2010. Inflammatory cytokine-induced intercellular adhesion molecule- 1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression. J. Immunol. 184: 2321-2328. https://doi.org/10.4049/jimmunol.0902023
- Corcione, A., F. Benvenuto, E. Ferretti, D. Giunti, V. Cappiello, F. Cazzanti, M. Risso, F. Gualandi, G. L. Mancardi, V. Pistoia, and A. Uccelli. 2006. Human mesenchymal stem cells modulate B-cell functions. Blood 107: 367-372. https://doi.org/10.1182/blood-2005-07-2657
- Tabera, S., J. A. Perez-Simon, M. Diez-Campelo, L. I. Sanchez- Abarca, B. Blanco, A. Lopez, A. Benito, E. Ocio, F. M. Sanchez-Guijo, C. Canizo, and J. F. San Miguel. 2008. The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes. Haematologica 93: 1301-1309. https://doi.org/10.3324/haematol.12857
Cited by
- Improved Protective Effect of Umbilical Cord Stem Cell Transplantation on Cisplatin-Induced Kidney Injury in Mice Pretreated with Antithymocyte Globulin vol.2016, pp.None, 2016, https://doi.org/10.1155/2016/3585362
- Intramyocardial implantation of differentiated rat bone marrow mesenchymal stem cells enhanced by TGF-β1 improves cardiac function in heart failure rats vol.49, pp.6, 2014, https://doi.org/10.1590/1414-431x20165273
- NCAM affects directional lamellipodia formation of BMSCs via β1 integrin signal-mediated cofilin activity vol.435, pp.1, 2014, https://doi.org/10.1007/s11010-017-3066-1
- (Mesenchymal) Stem Cell-Based Therapy in Cisplatin-Induced Acute Kidney Injury Animal Model: Risk of Immunogenicity and Tumorigenicity vol.2017, pp.None, 2014, https://doi.org/10.1155/2017/7304643
- The Beneficial Effect of Human Amnion Mesenchymal Cells in Inhibition of Inflammation and Induction of Neuronal Repair in EAE Mice vol.2018, pp.None, 2018, https://doi.org/10.1155/2018/5083797
- Comparative evaluation of mesenchymal stromal cells from umbilical cord and amniotic membrane in xeno-free conditions vol.19, pp.None, 2018, https://doi.org/10.1186/s12860-018-0178-8
- INFLUENCE OF NATIVE AND CRYOPRESERVED PLACENTAL DERIVATIVES ON THE SPLENOCYTE FUNCTIONAL CHARACTERISTICS IN VITRO vol.2018, pp.2, 2014, https://doi.org/10.29254/2077-4214-2018-2-144-221-224
- Neuroinflammation and Scarring After Spinal Cord Injury: Therapeutic Roles of MSCs on Inflammation and Glial Scar vol.12, pp.None, 2021, https://doi.org/10.3389/fimmu.2021.751021